スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
10 Hits
検索条件 : 絞込み (MeSH = Immunotherapy, Adoptive* / methods)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
KLM-1(RCB2138)
89441
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy.
Cell
2026-6-25
Pubmed
Full text
研究用ヒト臍帯血幹細胞
88212
Optimizing activation and culture conditions for the production of cord blood-derived CAR-T and natural killer cells.
Br J Haematol
2025-11-1
Pubmed
Full text
ヒト・動物細胞
OP9/N(RCB2926)
,
OP9/N-DLL1(RCB2927)
86596
Allogeneic iPSC-derived iNKT cells in recurrent head and neck cancer: a phase 1 trial.
Nat Commun
2025-11-26
Pubmed
Full text
ヒト・動物細胞
NB9(RCB0477)
86506
Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity.
Cancer Immunol Immunother
2026-1-3
Pubmed
Full text
ヒト・動物細胞
ACC-MESO-4(RCB2293)
86095
Improvement in the function of self-activating chimeric antigen receptor by replacing the linker sequence.
Front Immunol
2025-1-1
Pubmed
Full text
ヒト・動物細胞
TE-5(RCB1949)
,
TE-9(RCB1988)
,
TE-10(RCB2099)
,
TE-15(RCB1951)
83924
Development and optimization of Eva1 (
MPZL2
) targeting chimeric antigen receptor T cells.
J Immunother Cancer
2025-5-7
Pubmed
Full text
ヒト・動物細胞
Ba/F3
83315
Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma.
Cancer Immunol Immunother
2025-3-6
Pubmed
Full text
研究用ヒト臍帯血幹細胞
82383
Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells.
Cell Rep Med
2024-5-21
Pubmed
Full text
遺伝子材料
CSII-EF-MCS-IRES2-Venus (RDB04384)
,
pCMV-VSV-G-RSV-Rev (RDB04393)
,
pCAG-HIVgp (RDB04394)
81318
Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.
Cancer Immunol Immunother
2023-7-1
Pubmed
Full text
ヒト・動物細胞
OV2944-HM-1(RCB1483)
65457
Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models.
Cancer Immunol Immunother
2021-9-1
Pubmed
Full text